Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Feb-24 5:40 PM View:  | Eyepoint Pharmaceuticals, I... (EYPT) | 13-Feb-24 | Gift | 74,681 | -- | -- | 36% 210.24K to 284.92K | |
| 13-Feb-24 5:40 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 13-Feb-24 | Gift | 74,681 | -- | -- | (26%) 284.92K to 210.24K | |
| 13-Feb-24 5:40 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Payment of Exercise | 14,943 | $28.80 | $430,358.00 | (7%) 225.18K to 210.24K | |
| 13-Feb-24 5:40 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Option Exercise | 37,534 | -- | -- | 20% 187.65K to 225.18K | |
| 25-Jan-24 6:24 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 24-Jan-24 | Sale | 29,956 | $24.98 | $748,250.00 | (14%) 217.6K to 187.65K | |
| 25-Jan-24 6:24 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 23-Jan-24 | Private Sale | 5,044 | $24.97 | $125,950.00 | (2%) 222.65K to 217.6K | |
| 09-Jan-24 9:17 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 06-Jan-24 | Payment of Exercise | 23,043 | $20.40 | $470,077.00 | (12%) 193.48K to 170.44K | |
| 09-Jan-24 9:17 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 06-Jan-24 | Option Exercise | 75,133 | -- | -- | 63% 118.35K to 193.48K | |
| 06-Dec-23 5:18 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 04-Dec-23 | Private Sale | 20,000 | $20.76 | $415,200.00 | (10%) 190.56K to 170.56K | |
| 13-Feb-23 4:56 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-23 | Option Exercise | 37,533 | -- | -- | 25% 153.03K to 190.56K | |
| 02-Mar-22 6:21 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 28-Feb-22 | Option Exercise | 12,466 | -- | -- | 9% 137.81K to 150.28K | |
| 23-Feb-22 4:13 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 21-Feb-22 | Option Exercise | 13,717 | -- | -- | 11% 124.1K to 137.81K | |
| 11-Feb-22 10:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-22 | Option Exercise | 17,533 | -- | -- | 16% 106.56K to 124.1K | |
| 17-Nov-21 5:03 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 15-Nov-21 | Market Sale (Planned) | 10,000 | $20.15 | $201,480.00 | (9%) 113.55K to 103.55K | 30% |
| 15-Jun-21 5:04 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-21 | Option Exercise | 4,500 | -- | -- | 4% 109.05K to 113.55K | |
| 02-Mar-21 7:21 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 28-Feb-21 | Option Exercise | 12,467 | -- | -- | 13% 96.58K to 109.05K | |
| 23-Feb-21 9:01 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 21-Feb-21 | Option Exercise | 13,717 | -- | -- | 17% 82.86K to 96.58K | |
| 02-Jul-20 6:13 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 30-Jun-20 | Option Exercise | 124,667 | -- | -- | 19% 659.8K to 784.47K | |
| 30-Jun-20 7:40 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-20 | Option Exercise | 40,000 | -- | -- | 6% 619.8K to 659.8K | |
| 16-Jun-20 5:03 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-20 | Option Exercise | 45,000 | -- | -- | 8% 574.8K to 619.8K | |
| 11-Mar-20 8:40 AM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 10-Mar-20 | Market Purchase | 98,000 | $1.06 | $104,027.00 | 21% 476.8K to 574.8K | (56%) |
| 25-Feb-20 4:50 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 21-Feb-20 | Option Exercise | 137,174 | -- | -- | 40% 339.63K to 476.8K | |
| 15-Oct-19 6:04 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 12-Oct-19 | Payment of Exercise | 10,745 | $2.11 | $22,618.20 | (3%) 325.2K to 314.45K | 78% |
| 28-Jun-19 5:03 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-19 | Option Exercise | 40,000 | -- | -- | 14% 285.2K to 325.2K | |
| 17-Jun-19 5:42 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-19 | Option Exercise | 45,000 | -- | -- | 19% 240.2K to 285.2K | |
| 01-Apr-19 8:23 AM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 29-Mar-19 | Market Purchase | 28,500 | $1.76 | $50,245.50 | 13% 211.7K to 240.2K | (73%) |
| 16-Oct-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 12-Oct-18 | Grant | 76,667 | -- | -- | 57% 135.03K to 211.7K | |
| 29-Jun-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-18 | Option Exercise | 40,000 | -- | -- | 42% 95.03K to 135.03K | |
| 21-Mar-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 19-Mar-18 | Grant | 38,333 | -- | -- | 68% 56.7K to 95.03K | |
| 14-Jun-17 4:05 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 14-Jun-17 | Market Purchase | 56,700 | $1.76 | $99,962.10 | 100% 0 to 56.7K | (73%) |
| 18-Mar-16 4:57 PM View: | Mallinckrodt plc (MNKTQ) | 16-Mar-16 | Grant | 4,041 | -- | -- | 58% 6.92K to 10.96K | |
| 18-Mar-16 4:57 PM View: | Mallinckrodt plc (MNKTQ) | 16-Mar-16 | Payment of Exercise | 458 | $55.69 | $25,506.00 | (4%) 10.96K to 10.51K | 71% |
| 23-Mar-15 6:53 PM View: | Mallinckrodt plc (MNKTQ) | 19-Mar-15 | Grant | 1,715 | -- | -- | 33% 5.21K to 6.92K | |
| 09-Mar-15 4:40 PM View: | PDI Inc. (IDXG) | 05-Mar-15 | Grant | 444,364 | $1.73 | $768,750.00 | 46% 960.64K to 1.41M | (93%) |
| 30-Jan-15 9:31 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jan-15 | Disposition (other) | 10,000 | $36.53 | $365,300.00 | (100%) 10.0K to 0 | (2%) |
| 08-Dec-14 4:18 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 05-Dec-14 | Option Exercise | 25,000 | $19.67 | $491,650.00 | 143% 17.43K to 42.43K | |
| 08-Dec-14 4:18 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 05-Dec-14 | Market Option Sale | 25,000 | $34.00 | $850,000.00 | (59%) 42.43K to 17.43K | (1%) |
| 08-Dec-14 4:18 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 05-Dec-14 | Market Sale | 7,430 | $34.00 | $252,620.00 | (43%) 17.43K to 10.0K | (1%) |
| 12-Nov-14 9:25 AM View: | PDI Inc. (IDXG) | 10-Nov-14 | Market Purchase | 16,000 | $1.69 | $27,089.60 | 2% 1.0M to 1.02M | (92%) |
| 12-Nov-14 9:25 AM View: | PDI Inc. (IDXG) | 07-Nov-14 | Market Purchase | 33,000 | $1.77 | $58,502.40 | 3% 968.63K to 1.0M | (93%) |
| 07-Nov-14 7:14 AM View: | PDI Inc. (IDXG) | 06-Nov-14 | Market Purchase | 1,000 | $1.60 | $1,600.00 | < 1% 1.9M to 1.9M | (92%) |
| 07-Nov-14 7:14 AM View: | PDI Inc. (IDXG) | 05-Nov-14 | Market Purchase | 56,000 | $1.74 | $97,535.50 | 3% 1.84M to 1.9M | (93%) |
| 27-May-14 5:33 PM View: | Mallinckrodt plc (MNKTQ) | 22-May-14 | Grant | 572 | -- | -- | 12% 4.64K to 5.21K | |
| 22-May-14 4:07 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-May-14 | Grant | 5,000 | -- | -- | 40% 12.43K to 17.43K | |
| 27-Mar-14 7:57 AM View: | PDI Inc. (IDXG) | 25-Mar-14 | Payment of Exercise | 23,316 | $4.91 | $114,482.00 | (3%) 913.44K to 890.12K | |
| 24-Mar-14 5:32 PM View: | Mallinckrodt plc (MNKTQ) | 20-Mar-14 | Grant | 2,574 | -- | -- | 85% 3.03K to 5.61K | |
| 24-Mar-14 5:32 PM View: | Mallinckrodt plc (MNKTQ) | 20-Mar-14 | Payment of Exercise | 971 | $69.95 | $67,921.40 | (17%) 5.61K to 4.64K | 77% |
| 28-Feb-14 4:02 PM View: | PDI Inc. (IDXG) | 26-Feb-14 | Grant | 73,761 | $5.10 | $376,181.00 | 10% 765.92K to 839.68K | (97%) |
| 22-Jul-13 4:38 PM View: | Mallinckrodt plc (MNKTQ) | 18-Jul-13 | Grant | 3,034 | -- | -- | 100% 0 to 3.03K | |
| 03-May-13 2:05 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 01-May-13 | Grant | 5,000 | -- | -- | 67% 7.43K to 12.43K |